The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis.

This study was designed to investigate the modulatory effect of dietary soybean protein on the skeleton of an ovariectomized rat model with postmenopausal osteoporosis. Thirty-two female Sprague-Dawley rats were weight matched and divided into the following four experimental groups: Soy group, ovariectomized and fed soy protein diet; Estrogen group, ovariectomized, fed casein diet and injected with estrogen; Casein group, ovariectomized and fed casein diet; and Sham group, sham-operated and fed casein diet. The diets and estrogen were started two weeks after surgery, and continued for four weeks. Rats in the Sham, Soy and Estrogen groups had significantly higher (p < 0.05) femur and tibia ash content than those in the Casein group. Accordingly, the calcium content of the tibia and femur were also significantly higher (p < 0.05) in the Soy, Estrogen and Sham groups as compared to the Casein group. Serum total and bone-type alkaline phosphatase levels were both significantly lower (p < 0.05) in the Estrogen and Sham groups in relation to the Soy and Casein groups. This study demonstrated that a 22% soybean protein diet could be just as effective as daily estrogen administration in suppressing bone loss due to ovariectomy. However, unlike estrogen, soy protein diet did not have any uterotrophic effect and did not decrease the markers of bone turnover measured, suggesting a possible difference in the mechanism of action.

[1]  R. Lindsay,et al.  Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. , 1995, The Journal of clinical investigation.

[2]  S. Cummings,et al.  Estrogen Replacement Therapy and Fractures in Older Women , 1995, Annals of Internal Medicine.

[3]  J. Eaton-Evans Osteoporosis and the role of diet. , 1994, British journal of biomedical science.

[4]  N. Omi,et al.  Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. , 1994, Journal of nutritional science and vitaminology.

[5]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[6]  M. Horowitz Cytokines and estrogen in bone: anti-osteoporotic effects. , 1993, Science.

[7]  R. Moore,et al.  Effects of oophorectomy on biochemical and bone variables in the rat. , 1992, Bone and mineral.

[8]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[9]  D. Kalu The ovariectomized rat model of postmenopausal bone loss. , 1991, Bone and mineral.

[10]  B. Hollis,et al.  Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol , 1991 .

[11]  B. Riggs,et al.  Avian osteoclasts as estrogen target cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Rodan,et al.  Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Henderson,et al.  The cancer question: an overview of recent epidemiologic and retrospective data. , 1989, American journal of obstetrics and gynecology.

[14]  L. Avioli,et al.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  I. Yamazaki,et al.  Characteristics of an ovariectomized osteopenic rat model , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  R. Jaffe,et al.  Influence of preovulatory estradiol concentration on diurnal and pulsatile prolactin secretion patterns. , 1988, American journal of obstetrics and gynecology.

[17]  U. Barzel,et al.  Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review. , 1988, The American journal of medicine.

[18]  T. Wronski,et al.  Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. , 1988, Endocrinology.

[19]  E. Froesch,et al.  Enhanced osteoblast proliferation and collagen gene expression by estradiol. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Murphy,et al.  Oestrogenic potency of genistin and daidzin in mice. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  L. Melton,et al.  Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. , 1984, The New England journal of medicine.

[22]  J. Sjövall,et al.  Soya--a dietary source of the non-steroidal oestrogen equol in man and animals. , 1984, The Journal of endocrinology.

[23]  Everett M. Rogers,et al.  Consensus Development Conference , 1984 .

[24]  K. Copeland,et al.  Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons. , 1984, The Journal of clinical endocrinology and metabolism.

[25]  A. C. Eldridge Determination of isoflavones in soybean flours, protein concentrates, and isolates , 1982 .

[26]  D. Mishell,et al.  Feedback Effects of Estradiol and Progesterone upon Gonadotropin and Prolactin Release , 1981, Obstetrics and gynecology.

[27]  M. Whitehead,et al.  CALCITONIN AND THE CALCIUM-REGULATING HORMONES IN POSTMENOPAUSAL WOMEN: EFFECT OF OESTROGENS , 1981, The Lancet.

[28]  B. Y. Tang,et al.  Effect of equol on oestrogen receptors and on synthesis of DNA and protein in the immature rat uterus. , 1980, The Journal of endocrinology.

[29]  R. Brown,et al.  Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. , 1980, Journal of the National Cancer Institute.

[30]  W. McGuire,et al.  Phytoestrogen interaction with estrogen receptors in human breast cancer cells. , 1978, Endocrinology.

[31]  R. Lindsay,et al.  BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT , 1978 .

[32]  B. Hollis,et al.  Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. , 1996, The Journal of nutrition.

[33]  S. Schwartz,et al.  Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. , 1996, The Journal of clinical endocrinology and metabolism.

[34]  E. Barrett-Connor Hormone replacement and cancer. , 1992, British medical bulletin.

[35]  K. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells. , 1988, Science.

[36]  C. Lim,et al.  High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. , 1987, Journal of chromatography.

[37]  J L Kelsey,et al.  Epidemiology of osteoporosis and osteoporotic fractures. , 1985, Epidemiologic reviews.

[38]  P. Murphy Phytoestrogen content of processed soybean products , 1982 .

[39]  D. Patterson,et al.  Letter: The chance discovery of oestrogenic activity in laboratory rat cake. , 1975, Food and cosmetics toxicology.